心臓画像ソフトウェアの世界市場規模：画像モダリティ別、エンドユーザー別、用途別、地域別、予測

心臓画像ソフトウェアの市場規模と予測

心臓画像ソフトウェアの市場規模は、2024年に5億413万米ドルと評価され、2026～2032年にかけて8.40%のCAGRで成長し、2032年には9億681万米ドルに達すると予測されます。

心臓画像ソフトウェアの世界市場は、画像機器の技術向上、高齢化、心臓手術の増加により発展すると予測されています。心臓画像ソフトウェアの世界市場レポートは、同市場の総合的な評価を提供します。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

世界の心臓画像ソフトウェア市場の概要

心血管疾患（CVD）の有病率の上昇は、世界の入院の主な原因の1つです。WHOによると、CVDは世界の死亡原因の第一位であり、毎年1,800万人の命を奪っていると推定されています。心血管系疾患の頻度増加の結果、MRI、CTスキャン、血管造影、放射性化学物質、その他の放射光を使用して心臓関連の問題を特定する心臓画像ソフトウェアの必要性が高まっています。さらに、高齢者人口の増加、技術改善、CT、PETなどの心臓画像モダリティの使用増加、心血管疾患の根本原因の増加、これらの要因に対する市場参入企業の開発計画などの要因が、世界の心臓画像ソフトウェア市場に利益をもたらすと予測されています。

高コストの主な原因は、最新技術の高額な費用、診断検査の多用、薬理学的・内科的治療によるものです。米国では、画像診断費用は毎年1,000億米ドルを超えています。心血管画像診断（CVI）は画像診断の総負担の29％を占め、世界中で毎年実施されている数十億件の画像診断検査の少なくとも3分の1を占めています。さらに、この背景には、プロプライエタリなソフトウェア製品や、他のソフトウェアやハードウェアのプロバイダーとの相互運用性が組み込まれていることがあります。さらに、プロバイダー間で統一性がありません。このため、さまざまな供給者が製造した機器からデータを取得する可能性があり、多施設、集団ベースの研究を実施するのは困難です。このため、世界の心臓画像ソフトウェア市場の成長は鈍化すると予測されています。

目次

第1章 イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 市場概要

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 心臓画像ソフトウェア市場：画像モダリティ別

• 概要
• コンピュータ断層撮影
• 磁気共鳴
• 超音波画像
• X線画像診断
• 複合モダリティ

第6章 心臓画像ソフトウェア市場：エンドユーザー別

• 概要
• 病院および診療所
• 診断センター
• その他

第7章 心臓画像ソフトウェア市場：用途別

• 概要
• 画像診断
• 画像誘導治療
• 患者モニタリング

第8章 心臓画像ソフトウェア市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第10章 企業プロファイル

• Shimadzu Corporation
• Koninklijke Philips NV
• Siemens AG
• Canon Inc.
• Agfa-Gevaert Group
• General Electric
• Circle Cardiovascular
• Fujifilm Holdings Corporation
• Symphony Innovations, LLC
• Pie Medical Imaging

第11章 主な発展

• 製品上市／開発
• 合併と買収
• 事業拡大
• パートナーシップと提携

第12章 付録

• 関連調査

Cardiac Imaging Software Market Size And Forecast

Cardiac Imaging Software Market size was valued at USD 504.13 Million in 2024 and is projected to reach USD 906.81 Million by 2032, growing at a CAGR of 8.40% from 2026 to 2032.

The global Cardiac Imaging Software Market is predicted to develop due to technical improvements in imaging equipment, an older population, and an increase in heart procedures. The Global Cardiac Imaging Software Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Cardiac Imaging Software Market Size And Forecast

Cardiac Imaging Software Market size was valued at USD 504.13 Million in 2024 and is projected to reach USD 906.81 Million by 2032, growing at a CAGR of 8.40% from 2026 to 2032.

The global Cardiac Imaging Software Market is predicted to develop due to technical improvements in imaging equipment, an older population, and an increase in heart procedures. The Global Cardiac Imaging Software Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cardiac Imaging Software Market Overview

The rising prevalence of cardiovascular diseases (CVD) is one of the primary reasons for hospitalization worldwide. According to WHO, CVDs are the leading cause of mortality worldwide, claiming an estimated 18 million lives each year. As a result of the increased frequency of cardiovascular disorders, there is a greater need for cardiac imaging software to identify heart-related issues using MRI, CT scan, angiography, radioactive chemicals, and other types of radiant light. Furthermore, factors such as an increase in the older population, technological improvements, and increased use of cardiac imaging modalities such as CT, PET, and others, a Rise in underlying causes of cardiovascular disease, and market participants' development plans of these factors are projected to benefit the worldwide Cardiac Imaging Software Market.

The high cost is mostly due to the high expense of contemporary technology, the extensive use of diagnostic tests, and pharmacological and medical therapies. In the United States, imaging expenses surpass USD 100 billion each year. Cardiovascular imaging (CVI) accounts for 29 percent of the total imaging burden and at least one-third of the several billion medical imaging exams conducted worldwide each year. Furthermore, this was ascribed in part to proprietary software products and their built-in interoperability with other software and hardware providers. Furthermore, there is a lack of uniformity across providers. This makes multi-site, population-based research challenging to conduct, as data may be acquired from gear produced by various suppliers. This is projected to slow the global Cardiac Imaging Software Market's growth.

Global Cardiac Imaging Software Market Segmentation Analysis

The Global Cardiac Imaging Software Market is Segmented on the basis of Imaging Modalities, End-User, Application, and Geography.

Cardiac Imaging Software Market, By Imaging Modalities

• Computed Tomography
• Magnetic Resonance
• Ultrasound Imaging
• X-Ray Imaging
• Combined Modalities

Based on Imaging Modalities, the market is segmented into Computed Tomography, Magnetic Resonance, Ultrasound Imaging, X-Ray Imaging, and Combined Modalities. The computed tomography sector is predicted to increase at a healthy rate over the projection period because it is more efficient than conventional X-rays at delivering doses of cancer-damaging radiation.

Cardiac Imaging Software Market, By End-User

• Hospital & Clinics
• Diagnostic Centers
• Others

Based on End-User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. The market has seen a dramatic surge in the number of patients suffering from cardiovascular illnesses such as coronary heart disease, heart attacks, strokes, congenital heart disease, and others during the previous few years. The number of hospitals worldwide is steadily rising as the number of patients increases. By end-user, hospitals and clinics dominate the worldwide Cardiac Imaging Software Market. This share is mostly due to an increase in the number of individuals being monitored for a heart condition.

Cardiac Imaging Software Market, By Application

• Diagnostic Imaging
• Image Guided Treatment
• Patient Monitoring

Based on Application, the market is segmented into Diagnostic Imaging, Image Guided, and Patient Monitoring.

Cardiac Imaging Software Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, the Global Cardiac Imaging Software Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America Americas accounted for the majority of the global market because of the high prevalence of cardiovascular diseases, technological advancements, high disposable income, a growing older population, and a favorable regulatory environment. The rise in the frequency of heart diseases is linked to North America's dominance.

Key Players

The "Global Cardiac Imaging Software Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as Shimadzu Corporation, Koninklijke Philips NV, Siemens AG, Canon Inc., Agfa-Gevaert Group, General Electric, Circle Cardiovascular, Fujifilm Holdings Corporation, Symphony Innovation, LLC, and Pie Medical Imaging.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

• In June 2021, Circle Cardiovascular Imaging Inc. (Canada) formed an alliance with DiA Imaging Analysis (Israel). This collaboration will provide clients with all-in-one complete Ai-based cardiovascular imaging solutions, as well as new potential in multi-modality imaging solutions for physicians, patients, and hospitals globally. Circle's cardiac imaging offering will be strengthened by DiA's FDA-cleared and CE-marked LVivo Toolbox, a series of breakthrough AI-based cardiac ultrasound products.
• In June 2021, GE Healthcare (US) partnered with the American College of Cardiology (US) to develop artificial intelligence and digital health technology in cardiology.
• In March 2021, TeraRecon, one of the top healthcare imaging AI technology businesses, has been acquired by Symphony Innovation, LLC (US). Symphony AI Group has begun its new range of healthcare AI solutions centered on medical imaging with this purchase.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CARDIAC IMAGING SOFTWARE MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL CARDIAC IMAGING SOFTWARE MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL CARDIAC IMAGING SOFTWARE MARKET, BY IMAGING MODALITY

• 5.1 Overview
• 5.2 Computed Tomography
• 5.3 Magnetic Resonance
• 5.4 Ultrasound Imaging
• 5.5 X-Ray Imaging
• 5.6 Combined Modalities

6 GLOBAL CARDIAC IMAGING SOFTWARE MARKET, BY END-USER

• 6.1 Overview
• 6.2 Hospitals & Clinics
• 6.3 Diagnostics Centers
• 6.4 Others

7 GLOBAL CARDIAC IMAGING SOFTWARE MARKET, BY APPLICATION

• 7.1 Overview
• 7.2 Diagnostic Imaging
• 7.3 Image Guided Treatment
• 7.4 Patient Monitoring

8 GLOBAL CARDIAC IMAGING SOFTWARE MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL CARDIAC IMAGING SOFTWARE MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Shimadzu Corporation
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Koninklijke Philips NV
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Siemens AG
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Canon Inc.
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Agfa-Gevaert Group
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 General Electric
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Circle Cardiovascular
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Fujifilm Holdings Corporation
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Symphony Innovations, LLC
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Pie Medical Imaging
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1 Related Research